14 Both studies were limited by relatively short follow-up among the included trials, narrow systemic inclusion criteria, limited information on baseline diabetic retinopathy status and, most important, inadequate and non-rigorous methodologies for diabetic retinopathy evaluation
Letter: high-altitude cerebral oedema
Originally developed for type 2 diabetes, these drugs are now widely prescribed for weight management, sleep apnea, and other clinical uses
Lipolytic : stimulates the consumption of fats as a source of energy
Do not touch the injection button yet
Semaglutide: Albumin-Binding Powerhouse Semaglutide is a second-generation GLP-1 receptor agonist originally developed for type 2 diabetes and now widely used for weight loss